{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:41:04Z","timestamp":1794739264376,"version":"4.9.1"},"reference-count":223,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The International Pediatric Nephrology Association"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Idiopathic nephrotic syndrome newly affects 1\u20133 per 100,000 children per year. Approximately 85% of cases show complete remission of proteinuria following glucocorticoid treatment. Patients who do not achieve complete remission within 4\u20136\u00a0weeks of glucocorticoid treatment have steroid-resistant nephrotic syndrome (SRNS). In 10\u201330% of steroid-resistant patients, mutations in podocyte-associated genes can be detected, whereas an undefined circulating factor of immune origin is assumed in the remaining ones. Diagnosis and management of SRNS is a great challenge due to its heterogeneous etiology, frequent lack of remission by further immunosuppressive treatment, and severe complications including the development of end-stage kidney disease and recurrence after renal transplantation. A team of experts including pediatric nephrologists and renal geneticists from the International Pediatric Nephrology Association (IPNA), a renal pathologist, and an adult nephrologist have now developed comprehensive clinical practice recommendations on the diagnosis and management of SRNS in children. The team performed a systematic literature review on 9 clinically relevant PICO (\n                    <jats:underline>P<\/jats:underline>\n                    atient or\n                    <jats:underline>P<\/jats:underline>\n                    opulation covered,\n                    <jats:underline>I<\/jats:underline>\n                    ntervention,\n                    <jats:underline>C<\/jats:underline>\n                    omparator,\n                    <jats:underline>O<\/jats:underline>\n                    utcome) questions, formulated recommendations and formally graded them at a consensus meeting, with input from patient representatives and a dietician acting as external advisors and a voting panel of pediatric nephrologists. Research recommendations are also given.\n                  <\/jats:p>","DOI":"10.1007\/s00467-020-04519-1","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T08:02:56Z","timestamp":1588838576000},"page":"1529-1561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":372,"title":["IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome"],"prefix":"10.1007","volume":"35","author":[{"name":"on behalf of the International Pediatric Nephrology Association","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Trautmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vivarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Gipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ng Kar","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moin A","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Feltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"M\u00fcller-Deile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Ulrich","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yam Ngo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Smoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeoma","family":"Anochie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,7]]},"reference":[{"issue":"10141","key":"4519_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0140-6736(18)30536-1","volume":"392","author":"DG Noone","year":"2018","unstructured":"Noone DG, Iijima K, Parekh R (2018) Idiopathic nephrotic syndrome in children. Lancet 392(10141):61\u201374. https:\/\/doi.org\/10.1016\/s0140-6736(18)30536-1","journal-title":"Lancet"},{"issue":"9384","key":"4519_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/s0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362(9384):629\u2013639. https:\/\/doi.org\/10.1016\/s0140-6736(03)14184-0","journal-title":"Lancet"},{"issue":"12","key":"4519_CR3","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s004670100021","volume":"16","author":"PA McKinney","year":"2001","unstructured":"McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM (2001) Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediat Nephrol (Berlin, Germany) 16(12):1040\u20131044. https:\/\/doi.org\/10.1007\/s004670100021","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"8","key":"4519_CR4","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00467-011-1851-8","volume":"26","author":"L El Bakkali","year":"2011","unstructured":"El Bakkali L, Rodrigues Pereira R, Kuik DJ, Ket JC, van Wijk JA (2011) Nephrotic syndrome in the Netherlands: a population-based cohort study and a review of the literature. Pediat Nephrol (Berlin, Germany) 26(8):1241\u20131246. https:\/\/doi.org\/10.1007\/s00467-011-1851-8","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"12","key":"4519_CR5","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s00467-016-3509-z","volume":"31","author":"C Dossier","year":"2016","unstructured":"Dossier C, Lapidus N, Bayer F, Sellier-Leclerc AL, Boyer O, de Pontual L, May A, Nathanson S, Orzechowski C, Simon T, Carrat F, Deschenes G (2016) Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic? Pediat Nephrol (Berlin, Germany) 31(12):2299\u20132308. https:\/\/doi.org\/10.1007\/s00467-016-3509-z","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"3","key":"4519_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Gipson DS, Hodson EM (2013) Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediat Nephrol (Berlin, Germany) 28(3):415\u2013426. https:\/\/doi.org\/10.1007\/s00467-012-2310-x","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"12","key":"4519_CR7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/s2352-4642(18)30283-9","volume":"2","author":"K Tullus","year":"2018","unstructured":"Tullus K, Webb H, Bagga A (2018) Management of steroid-resistant nephrotic syndrome in children and adolescents. Lancet Child Adolesc Health 2(12):880\u2013890. https:\/\/doi.org\/10.1016\/s2352-4642(18)30283-9","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"4519_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.kint.2016.10.013","volume":"91","author":"A Bierzynska","year":"2017","unstructured":"Bierzynska A, McCarthy HJ, Soderquest K, Sen ES, Colby E, Ding WY, Nabhan MM, Kerecuk L, Hegde S, Hughes D, Marks S, Feather S, Jones C, Webb NJ, Ognjanovic M, Christian M, Gilbert RD, Sinha MD, Lord GM, Simpson M, Koziell AB, Welsh GI, Saleem MA (2017) Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. Kidney Int 91(4):937\u2013947. https:\/\/doi.org\/10.1016\/j.kint.2016.10.013","journal-title":"Kidney Int"},{"issue":"5","key":"4519_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/08860220500198623","volume":"27","author":"K El-Reshaid","year":"2005","unstructured":"El-Reshaid K, El-Reshaid W, Madda J (2005) Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis. Ren Fail 27(5):523\u2013530. https:\/\/doi.org\/10.1080\/08860220500198623","journal-title":"Ren Fail"},{"issue":"12","key":"4519_CR10","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1097\/tp.0000000000001897","volume":"101","author":"MG Sampson","year":"2017","unstructured":"Sampson MG (2017) The democratization of genomic inquiry empowers our understanding of nephrotic syndrome. Transplantation 101(12):2814\u20132815. https:\/\/doi.org\/10.1097\/tp.0000000000001897","journal-title":"Transplantation"},{"issue":"10","key":"4519_CR11","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1681\/asn.2016101121","volume":"28","author":"A Trautmann","year":"2017","unstructured":"Trautmann A, Schnaidt S, Lipska-Zietkiewicz BS, Bodria M, Ozaltin F, Emma F, Anarat A, Melk A, Azocar M, Oh J, Saeed B, Gheisari A, Caliskan S, Gellermann J, Higuita LMS, Jankauskiene A, Drozdz D, Mir S, Balat A, Szczepanska M, Paripovic D, Zurowska A, Bogdanovic R, Yilmaz A, Ranchin B, Baskin E, Erdogan O, Remuzzi G, Firszt-Adamczyk A, Kuzma-Mroczkowska E, Litwin M, Murer L, Tkaczyk M, Jardim H, Wasilewska A, Printza N, Fidan K, Simkova E, Borzecka H, Staude H, Hees K, Schaefer F (2017) Long-term outcome of steroid-resistant nephrotic syndrome in children. J Am Soc Nephrol 28(10):3055\u20133065. https:\/\/doi.org\/10.1681\/asn.2016101121","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"4519_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7326\/m16-1565","volume":"166","author":"Y Chen","year":"2017","unstructured":"Chen Y, Yang K, Marusic A, Qaseem A, Meerpohl JJ, Flottorp S, Akl EA, Schunemann HJ, Chan ES, Falck-Ytter Y, Ahmed F, Barber S, Chen C, Zhang M, Xu B, Tian J, Song F, Shang H, Tang K, Wang Q, Norris SL (2017) A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med 166(2):128\u2013132. https:\/\/doi.org\/10.7326\/m16-1565","journal-title":"Ann Intern Med"},{"issue":"4","key":"4519_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, Alderson P, Glasziou P, Falck-Ytter Y, Schunemann HJ (2011) GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 64(4):395\u2013400. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.09.012","journal-title":"J Clin Epidemiol"},{"key":"4519_CR14","doi-asserted-by":"publisher","unstructured":"Liu ID, Willis NS, Craig JC, Hodson EM (2019) Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database System Rev 2019(11). https:\/\/doi.org\/10.1002\/14651858.CD003594.pub6","DOI":"10.1002\/14651858.CD003594.pub6"},{"key":"4519_CR15","doi-asserted-by":"publisher","unstructured":"Drube J, Wan M, Bonthuis M, Wuhl E, Bacchetta J, Santos F, Grenda R, Edefonti A, Harambat J, Shroff R, Tonshoff B, Haffner D (2019) Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. 15(9):577-589. doi:https:\/\/doi.org\/10.1038\/s41581-019-0161-4","DOI":"10.1038\/s41581-019-0161-4"},{"key":"4519_CR16","doi-asserted-by":"publisher","unstructured":"Classifying recommendations for clinical practice guidelines (2004). Pediatrics 114 (3):874\u2013877. doi:https:\/\/doi.org\/10.1542\/peds.2004-1260","DOI":"10.1542\/peds.2004-1260"},{"key":"4519_CR17","doi-asserted-by":"publisher","unstructured":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children (1981). J Pediatr 98 (4):561\u2013564. doi:https:\/\/doi.org\/10.1016\/s0022-3476(81)80760-3","DOI":"10.1016\/s0022-3476(81)80760-3"},{"issue":"9","key":"4519_CR18","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00467-010-1544-8","volume":"25","author":"PR Slev","year":"2010","unstructured":"Slev PR, Bunker AM, Owen WE, Roberts WL (2010) Pediatric reference intervals for random urine calcium, phosphorus and total protein. Pediatr Nephrol (Berlin, Germany) 25(9):1707\u20131710. https:\/\/doi.org\/10.1007\/s00467-010-1544-8","journal-title":"Pediatr Nephrol (Berlin, Germany)"},{"issue":"6","key":"4519_CR19","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1542\/peds.105.6.1242","volume":"105","author":"RJ Hogg","year":"2000","unstructured":"Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J (2000) Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics 105(6):1242\u20131249. https:\/\/doi.org\/10.1542\/peds.105.6.1242","journal-title":"Pediatrics"},{"issue":"4","key":"4519_CR20","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/ajcn\/64.4.650","volume":"64","author":"M de Onis","year":"1996","unstructured":"de Onis M, Habicht JP (1996) Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. Am J Clin Nutr 64(4):650\u2013658. https:\/\/doi.org\/10.1093\/ajcn\/64.4.650","journal-title":"Am J Clin Nutr"},{"key":"4519_CR21","doi-asserted-by":"publisher","unstructured":"Bjork J, Nyman U (2019) Validation of standardized creatinine and cystatin C GFR estimating equations in a large multicentre European cohort of children 34 6):1087\u20131098. doi:https:\/\/doi.org\/10.1007\/s00467-018-4185-y","DOI":"10.1007\/s00467-018-4185-y"},{"issue":"10","key":"4519_CR22","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1681\/asn.2012121200","volume":"24","author":"J Gellermann","year":"2013","unstructured":"Gellermann J, Weber L, Pape L, Tonshoff B, Hoyer P, Querfeld U (2013) Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 24(10):1689\u20131697. https:\/\/doi.org\/10.1681\/asn.2012121200","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"4519_CR23","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/ndt\/gfv355","volume":"31","author":"S Lovric","year":"2016","unstructured":"Lovric S, Ashraf S, Tan W, Hildebrandt F (2016) Genetic testing in steroid-resistant nephrotic syndrome: when and how? Nephrol Dial Transplant 31(11):1802\u20131813. https:\/\/doi.org\/10.1093\/ndt\/gfv355","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"4519_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00467-017-3838-6","volume":"34","author":"R Preston","year":"2019","unstructured":"Preston R, Stuart HM, Lennon R (2019) Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how? Pediat Nephrol (Berlin, Germany) 34(2):195\u2013210. https:\/\/doi.org\/10.1007\/s00467-017-3838-6","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"Suppl 1","key":"4519_CR25","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.nephro.2017.01.014","volume":"13","author":"F Emma","year":"2017","unstructured":"Emma F, Salviati L (2017) Mitochondrial cytopathies and the kidney. Nephrol Therapeut 13(Suppl 1):S23\u2013s28. https:\/\/doi.org\/10.1016\/j.nephro.2017.01.014","journal-title":"Nephrol Therapeut"},{"key":"4519_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fped.2018.00200","volume":"6","author":"A Trautmann","year":"2018","unstructured":"Trautmann A, Lipska-Zietkiewicz BS, Schaefer F (2018) Exploring the clinical and genetic spectrum of steroid resistant nephrotic syndrome: the PodoNet Registry. Front Pediatr 6:200. https:\/\/doi.org\/10.3389\/fped.2018.00200","journal-title":"Front Pediatr"},{"issue":"12","key":"4519_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jmedgenet-2017-104811","volume":"54","author":"ES Sen","year":"2017","unstructured":"Sen ES, Dean P, Yarram-Smith L, Bierzynska A, Woodward G, Buxton C, Dennis G, Welsh GI, Williams M, Saleem MA (2017) Clinical genetic testing using a custom-designed steroid-resistant nephrotic syndrome gene panel: analysis and recommendations. J Med Genet 54(12):795\u2013804. https:\/\/doi.org\/10.1136\/jmedgenet-2017-104811","journal-title":"J Med Genet"},{"issue":"11","key":"4519_CR28","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1093\/ndt\/gfl347","volume":"21","author":"A Kitamura","year":"2006","unstructured":"Kitamura A, Tsukaguchi H, Iijima K, Araki J, Hattori M, Ikeda M, Honda M, Nozu K, Nakazato H, Yoshikawa N, Kagami S, Muramatsu M, Choi Y, Cheong HI, Doi T (2006) Genetics and clinical features of 15 Asian families with steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 21(11):3133\u20133138. https:\/\/doi.org\/10.1093\/ndt\/gfl347","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"4519_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00467-003-1120-6","volume":"18","author":"K Maruyama","year":"2003","unstructured":"Maruyama K, Iijima K, Ikeda M, Kitamura A, Tsukaguchi H, Yoshiya K, Hoshii S, Wada N, Uemura O, Satomura K, Honda M, Yoshikawa N (2003) NPHS2 mutations in sporadic steroid-resistant nephrotic syndrome in Japanese children. Pediat Nephrol (Berlin, Germany) 18(5):412\u2013416. https:\/\/doi.org\/10.1007\/s00467-003-1120-6","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"5","key":"4519_CR30","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/ndt\/gfh769","volume":"20","author":"Z Yu","year":"2005","unstructured":"Yu Z, Ding J, Huang J, Yao Y, Xiao H, Zhang J, Liu J, Yang J (2005) Mutations in NPHS2 in sporadic steroid-resistant nephrotic syndrome in Chinese children. Nephrol Dial Transplant 20(5):902\u2013908. https:\/\/doi.org\/10.1093\/ndt\/gfh769","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"4519_CR31","first-page":"273","volume":"31","author":"IC Anochie","year":"2012","unstructured":"Anochie IC, Eke FU, Okpere AN (2012) Familial focal segmental glomerulosclerosis (FSGS) in a Nigerian family and exclusion of mutations in NPHS2,WT1 and APOL1. West Afr J Med 31(4):273\u2013276","journal-title":"West Afr J Med"},{"issue":"5","key":"4519_CR32","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.kint.2017.09.028","volume":"93","author":"MS Hommos","year":"2018","unstructured":"Hommos MS, Zeng C, Liu Z, Troost JP, Rosenberg AZ, Palmer M, Kremers WK, Cornell LD, Fervenza FC, Barisoni L, Rule AD (2018) Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment. Kidney Int 93(5):1175\u20131182. https:\/\/doi.org\/10.1016\/j.kint.2017.09.028","journal-title":"Kidney Int"},{"issue":"4","key":"4519_CR33","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2215\/cjn.06260614","volume":"10","author":"A Trautmann","year":"2015","unstructured":"Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, Erdogan O, Akman S, Dusek J, Davitaia T, Ozkaya O, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, Ozcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F (2015) Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol 10(4):592\u2013600. https:\/\/doi.org\/10.2215\/cjn.06260614","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"4519_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the. Am College Med Genet Genom Assoc Molec Pathol 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Am College Med Genet Genom Assoc Molec Pathol"},{"key":"4519_CR35","doi-asserted-by":"publisher","unstructured":"Watanabe A, Feltran LS, Sampson MG (2019) Genetics of nephrotic syndrome presenting in childhood: Core Curriculum 2019. Genet Med. https:\/\/doi.org\/10.1053\/j.ajkd.2019.01.033","DOI":"10.1053\/j.ajkd.2019.01.033"},{"issue":"1","key":"4519_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00467-015-3167-6","volume":"31","author":"S Weber","year":"2016","unstructured":"Weber S, Buscher AK, Hagmann H, Liebau MC, Heberle C, Ludwig M, Rath S, Alberer M, Beissert A, Zenker M, Hoyer PF, Konrad M, Klein HG, Hoefele J (2016) Dealing with the incidental finding of secondary variants by the example of SRNS patients undergoing targeted next-generation sequencing. Pediat Nephrol (Berlin, Germany) 31(1):73\u201381. https:\/\/doi.org\/10.1007\/s00467-015-3167-6","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"3","key":"4519_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nrneph.2012.286","volume":"9","author":"RA Gbadegesin","year":"2013","unstructured":"Gbadegesin RA, Winn MP, Smoyer WE (2013) Genetic testing in nephrotic syndrome--challenges and opportunities. Pediat Nephrol (Berlin, Germany) 9(3):179\u2013184. https:\/\/doi.org\/10.1038\/nrneph.2012.286","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"17","key":"4519_CR38","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","volume":"361","author":"E Wuhl","year":"2009","unstructured":"Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Moller K, Wigger M, Peruzzi L, Mehls O, Schaefer F (2009) Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361(17):1639\u20131650. https:\/\/doi.org\/10.1056\/NEJMoa0902066","journal-title":"N Engl J Med"},{"issue":"1","key":"4519_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00467-003-1314-y","volume":"19","author":"A Bagga","year":"2004","unstructured":"Bagga A, Mudigoudar BD, Hari P, Vasudev V (2004) Enalapril dosage in steroid-resistant nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 19(1):45\u201350. https:\/\/doi.org\/10.1007\/s00467-003-1314-y","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"8","key":"4519_CR40","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1681\/asn.2018010036","volume":"29","author":"SM van den Belt","year":"2018","unstructured":"van den Belt SM, Heerspink HJL, Gracchi V, de Zeeuw D, Wuhl E, Schaefer F (2018) Early proteinuria lowering by angiotensin-converting enzyme inhibition predicts renal survival in children with CKD. Pediat Nephrol (Berlin, Germany) 29(8):2225\u20132233. https:\/\/doi.org\/10.1681\/asn.2018010036","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"5","key":"4519_CR41","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","volume":"67","author":"X Xie","year":"2016","unstructured":"Xie X, Liu Y, Perkovic V, Li X, Ninomiya T, Hou W, Zhao N, Liu L, Lv J, Zhang H, Wang H (2016) Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials. Am J Kidney Dis 67(5):728\u2013741. https:\/\/doi.org\/10.1053\/j.ajkd.2015.10.011","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4519_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00467-016-3495-1","volume":"32","author":"P Ruggenenti","year":"2017","unstructured":"Ruggenenti P, Cravedi P, Chianca A, Caruso M, Remuzzi G (2017) Achieving remission of proteinuria in childhood. CKD. 32(2):321\u2013330. https:\/\/doi.org\/10.1007\/s00467-016-3495-1","journal-title":"CKD."},{"issue":"7","key":"4519_CR43","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00467-006-0096-4","volume":"21","author":"Z Yi","year":"2006","unstructured":"Yi Z, Li Z, Wu XC, He QN, Dang XQ, He XJ (2006) Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 21(7):967\u2013972. https:\/\/doi.org\/10.1007\/s00467-006-0096-4","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"6","key":"4519_CR44","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1053\/j.ajkd.2018.06.010","volume":"72","author":"MR Weir","year":"2018","unstructured":"Weir MR, Lakkis JI, Jaar B, Rocco MV, Choi MJ, Kramer HJ, Ku E (2018) Use of renin-angiotensin system blockade in advanced CKD: an NKF-KDOQI controversies report. Am J Kidney Dis 72(6):873\u2013884. https:\/\/doi.org\/10.1053\/j.ajkd.2018.06.010","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"4519_CR45","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/archdischild-2011-300172","volume":"96","author":"K Tullus","year":"2011","unstructured":"Tullus K (2011) Safety concerns of angiotensin II receptor blockers in preschool children. Arch Dis Child 96(9):881\u2013882. https:\/\/doi.org\/10.1136\/archdischild-2011-300172","journal-title":"Arch Dis Child"},{"issue":"9","key":"4519_CR46","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00467-018-4046-8","volume":"34","author":"BR Stotter","year":"2019","unstructured":"Stotter BR, Ferguson MA (2019) Should ACE inhibitors and ARBs be used in combination in children? Pediat Nephrol (Berlin, Germany) 34(9):1521\u20131532. https:\/\/doi.org\/10.1007\/s00467-018-4046-8","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"8","key":"4519_CR47","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/bdra.23027","volume":"94","author":"JE Polifka","year":"2012","unstructured":"Polifka JE (2012) Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence. Birth Defects Res A, Clin Molec Teratol 94(8):576\u2013598. https:\/\/doi.org\/10.1002\/bdra.23027","journal-title":"Birth Defects Res A, Clin Molec Teratol"},{"issue":"1","key":"4519_CR48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1681\/ASN.V7156","volume":"7","author":"KV Lieberman","year":"1996","unstructured":"Lieberman KV, Tejani A (1996) A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 7(1):56\u201363","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"4519_CR49","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/archpedi.1988.02150090083029","volume":"142","author":"EH Garin","year":"1988","unstructured":"Garin EH, Orak JK, Hiott KL, Sutherland SE (1988) Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study. Am J Dis Children (1960) 142(9):985\u2013988. https:\/\/doi.org\/10.1001\/archpedi.1988.02150090083029","journal-title":"Am J Dis Children (1960)"},{"issue":"6","key":"4519_CR50","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/ki.1993.194","volume":"43","author":"C Ponticelli","year":"1993","unstructured":"Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, Rinaldi S, Ghio L, Lusvarghi E, Gusmano R, Locatelli F et al (1993) A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43(6):1377\u20131384. https:\/\/doi.org\/10.1038\/ki.1993.194","journal-title":"Kidney Int"},{"issue":"4","key":"4519_CR51","first-page":"190","volume":"12","author":"SKMA Bhaumik","year":"2002","unstructured":"Bhaumik SKMA, Barman SK (2002) Comparison of pulse methylprednisolone vs. cyclosporine based therapy in steroid resistant focal segmental glomerulosclerosis (abstract). Indian J Nephrol 12(4):190","journal-title":"Indian J Nephrol"},{"issue":"8","key":"4519_CR52","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/ki.2011.195","volume":"80","author":"DS Gipson","year":"2011","unstructured":"Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Hogan SL, Middleton JP, Vehaskari VM, Flynn PA, Powell LM, Vento SM, McMahan JL, Siegel N, D'Agati VD, Friedman AL (2011) Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int 80(8):868\u2013878. https:\/\/doi.org\/10.1038\/ki.2011.195","journal-title":"Kidney Int"},{"issue":"5","key":"4519_CR53","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1053\/j.ajkd.2008.11.033","volume":"53","author":"S Choudhry","year":"2009","unstructured":"Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A (2009) Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. Am J Kidney Dis 53(5):760\u2013769. https:\/\/doi.org\/10.1053\/j.ajkd.2008.11.033","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"4519_CR54","first-page":"1804","volume":"25","author":"S Valverde","year":"2010","unstructured":"Valverde S (2010) Efficacy of prednison-tacrolimus vs. prednisone-cyclosporine in steroid-resistant nephrotic syndrome [abstract]. Pediatr Nephrol 25(9):1804","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"4519_CR55","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/ki.2012.238","volume":"82","author":"A Gulati","year":"2012","unstructured":"Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A (2012) Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome. Kidney Int 82(10):1130\u20131135. https:\/\/doi.org\/10.1038\/ki.2012.238","journal-title":"Kidney Int"},{"issue":"9","key":"4519_CR56","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00467-008-0794-1","volume":"23","author":"C Plank","year":"2008","unstructured":"Plank C, Kalb V, Hinkes B, Hildebrandt F, Gefeller O, Rascher W (2008) Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft fur Padiatrische Nephrologie. Pediat Nephrol (Berlin, Germany) 23(9):1483\u20131493. https:\/\/doi.org\/10.1007\/s00467-008-0794-1","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"1","key":"4519_CR57","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s00467-017-3634-3.10.1016\/j.kint.2017.01.019","volume":"92","author":"A Sinha","year":"2017","unstructured":"Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A (2017) Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 92(1):248\u2013257. https:\/\/doi.org\/10.1007\/s00467-017-3634-3.10.1016\/j.kint.2017.01.019","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"4","key":"4519_CR58","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/08923979309035241","volume":"15","author":"C Ponticelli","year":"1993","unstructured":"Ponticelli C (1993) Cyclosporine in idiopathic nephrotic syndrome. Immunopharmacol Immunotoxicol 15(4):479\u2013489. https:\/\/doi.org\/10.3109\/08923979309035241","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"12","key":"4519_CR59","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/sj.ki.5002553","volume":"72","author":"DC Cattran","year":"2007","unstructured":"Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, Ponticelli C, Saito T, Choukroun G, Nachman P, Praga M, Yoshikawa N (2007) Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney Int 72(12):1429\u20131447. https:\/\/doi.org\/10.1038\/sj.ki.5002553","journal-title":"Kidney Int"},{"issue":"5","key":"4519_CR60","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s004670050167","volume":"10","author":"P Tarshish","year":"1996","unstructured":"Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1996) Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediat Nephrol (Berlin, Germany) 10(5):590\u2013593","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"key":"4519_CR61","doi-asserted-by":"crossref","unstructured":"Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children (1974). Lancet (London, England) 2 (7878):423\u2013427","DOI":"10.1016\/S0140-6736(74)91814-5"},{"issue":"9","key":"4519_CR62","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00467-008-0860-8","volume":"23","author":"M Mantan","year":"2008","unstructured":"Mantan M, Sriram CS, Hari P, Dinda A, Bagga A (2008) Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 23(9):1495\u20131502. https:\/\/doi.org\/10.1007\/s00467-008-0860-8","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"1","key":"4519_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/bf00868243","volume":"8","author":"R Elhence","year":"1994","unstructured":"Elhence R, Gulati S, Kher V, Gupta A, Sharma RK (1994) Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome. Pediatr Nephrol (Berlin, Germany) 8(1):1\u20133. https:\/\/doi.org\/10.1007\/bf00868243","journal-title":"Pediatr Nephrol (Berlin, Germany)"},{"issue":"6","key":"4519_CR64","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4103\/ijn.IJN_201_16","volume":"27","author":"KM Shah","year":"2017","unstructured":"Shah KM, Ohri AJ, Ali US (2017) A randomized controlled trial of intravenous versus oral cyclophosphamide in steroid-resistant nephrotic syndrome in children. Indian J Nephrol 27(6):430\u2013434. https:\/\/doi.org\/10.4103\/ijn.IJN_201_16","journal-title":"Indian J Nephrol"},{"issue":"4","key":"4519_CR65","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00467-003-1095-3","volume":"18","author":"A Bajpai","year":"2003","unstructured":"Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN (2003) Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 18(4):351\u2013356. https:\/\/doi.org\/10.1007\/s00467-003-1095-3","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"2","key":"4519_CR66","first-page":"141","volume":"37","author":"S Gulati","year":"2000","unstructured":"Gulati S, Kher V (2000) Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis. Indian Pediatr 37(2):141\u2013148","journal-title":"Indian Pediatr"},{"issue":"12","key":"4519_CR67","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1097\/01.tp.0000268306.41196.2c","volume":"83","author":"SR Knight","year":"2007","unstructured":"Knight SR, Morris PJ (2007) The clinical benefits of cyclosporine C2-level monitoring: a systematic review. Transplantation 83(12):1525\u20131535. https:\/\/doi.org\/10.1097\/01.tp.0000268306.41196.2c","journal-title":"Transplantation"},{"issue":"9","key":"4519_CR68","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2215\/cjn.01520209","volume":"4","author":"S Kengne-Wafo","year":"2009","unstructured":"Kengne-Wafo S, Massella L, Diomedi-Camassei F, Gianviti A, Vivarelli M, Greco M, Stringini GR, Emma F (2009) Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome. Clin J Am Soc Nephrol 4(9):1409\u20131416. https:\/\/doi.org\/10.2215\/cjn.01520209","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"4519_CR69","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00467-008-0899-6","volume":"23","author":"EM Dorresteijn","year":"2008","unstructured":"Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN, Nauta J, Hop WC, van der Heijden AJ (2008) Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 23(11):2013\u20132020. https:\/\/doi.org\/10.1007\/s00467-008-0899-6","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"10","key":"4519_CR70","first-page":"1852","volume":"31","author":"GMRM Uddin","year":"2016","unstructured":"Uddin GMRM, Rahman MH, Roy RR, Begum A, Huque SS (2016) Comparative efficacy of mycophenolate mofetil and cyclosporine in children with frequent relapse nephrotic syndrome [abstract]. Pediatr Nephrol 31(10):1852\u20131853","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"4519_CR71","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1093\/ndt\/gfr572","volume":"27","author":"J Gellermann","year":"2012","unstructured":"Gellermann J, Ehrich JH, Querfeld U (2012) Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 27(5):1970\u20131978. https:\/\/doi.org\/10.1093\/ndt\/gfr572","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"4519_CR72","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.humpath.2014.09.003","volume":"46","author":"L Singh","year":"2015","unstructured":"Singh L, Singh G, Sharma A, Sinha A, Bagga A, Dinda AK (2015) A comparative study on renal biopsy before and after long-term calcineurin inhibitors therapy: an insight for pathogenesis of its toxicity. Hum Pathol 46(1):34\u201339. https:\/\/doi.org\/10.1016\/j.humpath.2014.09.003","journal-title":"Hum Pathol"},{"issue":"6 Pt 1","key":"4519_CR73","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/s0022-3476(05)82020-7","volume":"125","author":"P Niaudet","year":"1994","unstructured":"Niaudet P (1994) Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology. J Pediatr 125(6 Pt 1):981\u2013986. https:\/\/doi.org\/10.1016\/s0022-3476(05)82020-7","journal-title":"J Pediatr"},{"issue":"8","key":"4519_CR74","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/ndt\/gfm092","volume":"22","author":"JH Ehrich","year":"2007","unstructured":"Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J (2007) Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol Dial Transplant 22(8):2183\u20132193. https:\/\/doi.org\/10.1093\/ndt\/gfm092","journal-title":"Nephrol Dial Transplant"},{"issue":"26","key":"4519_CR75","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1056\/NEJMc063706","volume":"356","author":"A Bagga","year":"2007","unstructured":"Bagga A, Sinha A, Moudgil A (2007) Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 356(26):2751\u20132752. https:\/\/doi.org\/10.1056\/NEJMc063706","journal-title":"N Engl J Med"},{"issue":"3","key":"4519_CR76","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00467-007-0640-x","volume":"23","author":"M Nakayama","year":"2008","unstructured":"Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, Iijima K (2008) Rituximab for refractory focal segmental glomerulosclerosis. Pediat Nephrol (Berlin, Germany) 23(3):481\u2013485. https:\/\/doi.org\/10.1007\/s00467-007-0640-x","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"12","key":"4519_CR77","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.2215\/cjn.03470410","volume":"5","author":"A Gulati","year":"2010","unstructured":"Gulati A, Sinha A, Jordan SC, Hari P, Dinda AK, Sharma S, Srivastava RN, Moudgil A, Bagga A (2010) Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 5(12):2207\u20132212. https:\/\/doi.org\/10.2215\/cjn.03470410","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"4519_CR78","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00467-012-2319-1","volume":"28","author":"S Ito","year":"2013","unstructured":"Ito S, Kamei K, Ogura M, Udagawa T, Fujinaga S, Saito M, Sako M, Iijima K (2013) Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 28(2):257\u2013264. https:\/\/doi.org\/10.1007\/s00467-012-2319-1","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"2","key":"4519_CR79","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00467-015-3205-4","volume":"31","author":"K Kamei","year":"2016","unstructured":"Kamei K, Ishikura K (2016) Rituximab treatment for refractory steroid-resistant nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 31(2):337\u2013338. https:\/\/doi.org\/10.1007\/s00467-015-3205-4","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"1","key":"4519_CR80","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s13312-017-0996-3","volume":"54","author":"S Fujinaga","year":"2017","unstructured":"Fujinaga S, Sakuraya K (2017) Repeated administrations of rituximab along with steroids and immunosuppressive agents in refractory steroid-resistant nephrotic syndrome. Indian Pediatr 54(1):49\u201350. https:\/\/doi.org\/10.1007\/s13312-017-0996-3","journal-title":"Indian Pediatr"},{"key":"4519_CR81","doi-asserted-by":"publisher","unstructured":"Zachwieja J, Silska-Dittmar M (2018) Multicenter analysis of the efficacy and safety of a non-standard immunosuppressive therapy with rituximab in children with steroid-resistant nephrotic syndrome. doi:https:\/\/doi.org\/10.1111\/1440-1681.13046","DOI":"10.1111\/1440-1681.13046"},{"issue":"1","key":"4519_CR82","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12519-014-0453-5","volume":"10","author":"L Sun","year":"2014","unstructured":"Sun L, Xu H, Shen Q, Cao Q, Rao J, Liu HM, Fang XY, Zhou LJ (2014) Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai. World J Pediatr 10(1):59\u201363. https:\/\/doi.org\/10.1007\/s12519-014-0453-5","journal-title":"World J Pediatr"},{"issue":"5","key":"4519_CR83","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00467-011-1778-0","volume":"26","author":"JA Kari","year":"2011","unstructured":"Kari JA, El-Morshedy SM, El-Desoky S, Alshaya HO, Rahim KA, Edrees BM (2011) Rituximab for refractory cases of childhood nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 26(5):733\u2013737. https:\/\/doi.org\/10.1007\/s00467-011-1778-0","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"1","key":"4519_CR84","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1542\/peds.2015-0486","volume":"136","author":"B Basu","year":"2015","unstructured":"Basu B, Mahapatra TK, Mondal N (2015) Mycophenolate mofetil following rituximab in children with steroid-resistant nephrotic syndrome. Pediatrics 136(1):e132\u2013e139. https:\/\/doi.org\/10.1542\/peds.2015-0486","journal-title":"Pediatrics"},{"issue":"6","key":"4519_CR85","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1681\/asn.2011080775","volume":"23","author":"A Magnasco","year":"2012","unstructured":"Magnasco A, Ravani P, Edefonti A, Murer L, Ghio L, Belingheri M, Benetti E, Murtas C, Messina G, Massella L, Porcellini MG, Montagna M, Regazzi M, Scolari F, Ghiggeri GM (2012) Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol 23(6):1117\u20131124. https:\/\/doi.org\/10.1681\/asn.2011080775","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"4519_CR86","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00467-018-4145-6","volume":"34","author":"S Fujinaga","year":"2019","unstructured":"Fujinaga S, Nishino T, Umeda C, Tomii Y, Watanabe Y, Sakuraya K (2019) Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 34(2):353\u2013357. https:\/\/doi.org\/10.1007\/s00467-018-4145-6","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"key":"4519_CR87","doi-asserted-by":"publisher","unstructured":"Kronbichler A, Gauckler P, Lee KH, Shin JI, Malvezzi P, Mayer G (2019) Immunoadsorption in nephrotic syndrome: where are we now and where are we going from here? Atheroscler Suppl. https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2019.08.027","DOI":"10.1016\/j.atherosclerosissup.2019.08.027"},{"issue":"1","key":"4519_CR88","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00467-016-3498-y","volume":"32","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Colucci M, Bonanni A, Verzani M, Serafinelli J, Emma F, Ghiggeri G (2017) Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab. Pediat Nephrol (Berlin, Germany) 32(1):181\u2013184. https:\/\/doi.org\/10.1007\/s00467-016-3498-y","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"5","key":"4519_CR89","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00467-017-3621-8","volume":"32","author":"CS Wang","year":"2017","unstructured":"Wang CS (2017) Ofatumumab for the treatment of childhood nephrotic syndrome. F1000Research 32(5):835\u2013841. https:\/\/doi.org\/10.1007\/s00467-017-3621-8","journal-title":"F1000Research"},{"issue":"13","key":"4519_CR90","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMc1308488","volume":"370","author":"B Basu","year":"2014","unstructured":"Basu B (2014) Ofatumumab for rituximab-resistant nephrotic syndrome. N Engl J Med 370(13):1268\u20131270. https:\/\/doi.org\/10.1056\/NEJMc1308488","journal-title":"N Engl J Med"},{"issue":"2","key":"4519_CR91","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000437338","volume":"5","author":"E Muso","year":"2015","unstructured":"Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Takemura T, Yuzawa Y, Ogahara S, Sugiyama S, Iino Y, Sakai S, Ogura Y, Yukawa S, Nishizawa Y, Yorioka N, Imai E, Matsuo S, Saito T (2015) A prospective observational survey on the long-term effect of LDL apheresis on drug-resistant nephrotic syndrome. Nephron Extra 5(2):58\u201366. https:\/\/doi.org\/10.1159\/000437338","journal-title":"Nephron Extra"},{"key":"4519_CR92","doi-asserted-by":"publisher","unstructured":"Shah L (2019) LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients. Int J Genom. https:\/\/doi.org\/10.1155\/2019\/2197837.10.1007\/s00467-019-04296-6","DOI":"10.1155\/2019\/2197837.10.1007\/s00467-019-04296-6"},{"issue":"10","key":"4519_CR93","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s00467-018-4061-9","volume":"34","author":"R Raina","year":"2019","unstructured":"Raina R, Krishnappa V (2019) An update on LDL apheresis for nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 34(10):1655\u20131669. https:\/\/doi.org\/10.1007\/s00467-018-4061-9","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"25","key":"4519_CR94","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","volume":"369","author":"CC Yu","year":"2013","unstructured":"Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, Chen L, Ciancio G, Faridi MH, Behr D, Campbell KN, Chang JM, Chen HC, Oh J, Faul C, Arnaout MA, Fiorina P, Gupta V, Greka A, Burke GW 3rd, Mundel P (2013) Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 369(25):2416\u20132423. https:\/\/doi.org\/10.1056\/NEJMoa1304572","journal-title":"N Engl J Med"},{"key":"4519_CR95","doi-asserted-by":"publisher","unstructured":"Jayaraman VK (2016) Thomas M (2016) Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis. BMJ Case Reports. https:\/\/doi.org\/10.1136\/bcr-2016-214396","DOI":"10.1136\/bcr-2016-214396"},{"issue":"5","key":"4519_CR96","doi-asserted-by":"publisher","first-page":"376","DOI":"10.5414\/cn109290","volume":"89","author":"D Dado","year":"2018","unstructured":"Dado D, Parikh S, Ayoub I, Rovin B, Nadasdy T, Hebert L (2018) Abatacept efficacy in steroid-resistant minimal-change disease revealed by the speed of proteinuria reduction after the start of abatacept. Clin Nephrol 89(5):376\u2013380. https:\/\/doi.org\/10.5414\/cn109290","journal-title":"Clin Nephrol"},{"issue":"5","key":"4519_CR97","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00467-013-2731-1","volume":"29","author":"OP Mishra","year":"2014","unstructured":"Mishra OP, Singh AK (2014) Galactose treatment in focal and segmental glomerulosclerosis. Pediat Nephrol (Berlin, Germany) 29(5):935. https:\/\/doi.org\/10.1007\/s00467-013-2731-1","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"11","key":"4519_CR98","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s00467-013-2539-z","volume":"28","author":"K Sgambat","year":"2013","unstructured":"Sgambat K, Banks M, Moudgil A (2013) Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome. Pediatr Nephrol (Berlin, Germany) 28(11):2131\u20132135. https:\/\/doi.org\/10.1007\/s00467-013-2539-z","journal-title":"Pediatr Nephrol (Berlin, Germany)"},{"issue":"5","key":"4519_CR99","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00467-013-2700-8","volume":"29","author":"H Trachtman","year":"2014","unstructured":"Trachtman H, Savin VJ (2014) Galactose treatment in focal segmental glomerulosclerosis. Pediat Nephrol (Berlin, Germany) 29(5):931. https:\/\/doi.org\/10.1007\/s00467-013-2700-8","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"10","key":"4519_CR100","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1681\/asn.2016101121","volume":"28","author":"A Trautmann","year":"2017","unstructured":"Trautmann A, Schnaidt S, Lipska-Zietkiewicz BS, Bodria M, Ozaltin F, Emma F, Anarat A, Melk A, Azocar M, Oh J, Saeed B, Gheisari A, Caliskan S, Gellermann J, Higuita LMS, Jankauskiene A, Drozdz D, Mir S, Balat A, Szczepanska M, Paripovic D, Zurowska A, Bogdanovic R, Yilmaz A, Ranchin B, Baskin E, Erdogan O, Remuzzi G, Firszt-Adamczyk A, Kuzma-Mroczkowska E, Litwin M, Murer L, Tkaczyk M, Jardim H, Wasilewska A, Printza N, Fidan K, Simkova E, Borzecka H, Staude H, Hees K, Schaefer F (2017) Long-term outcome of steroid-resistant nephrotic syndrome in children. Biomed Res Int 28(10):3055\u20133065. https:\/\/doi.org\/10.1681\/asn.2016101121","journal-title":"Biomed Res Int"},{"issue":"2","key":"4519_CR101","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2215\/cjn.07370715","volume":"11","author":"AK Buscher","year":"2016","unstructured":"Buscher AK, Beck BB, Melk A, Hoefele J, Kranz B, Bamborschke D, Baig S, Lange-Sperandio B, Jungraithmayr T, Weber LT, Kemper MJ, Tonshoff B, Hoyer PF, Konrad M, Weber S (2016) Rapid response to Cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 11(2):245\u2013253. https:\/\/doi.org\/10.2215\/cjn.07370715","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"4519_CR102","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2215\/cjn.01190210","volume":"5","author":"AK Buscher","year":"2010","unstructured":"Buscher AK, Kranz B, Buscher R, Hildebrandt F, Dworniczak B, Pennekamp P, Kuwertz-Broking E, Wingen AM, John U, Kemper M, Monnens L, Hoyer PF, Weber S, Konrad M (2010) Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 5(11):2075\u20132084. https:\/\/doi.org\/10.2215\/cjn.01190210","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"4519_CR103","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00467-018-3937-z","volume":"33","author":"MC Starr","year":"2018","unstructured":"Starr MC, Chang IJ, Finn LS, Sun A, Larson AA, Goebel J, Hanevold C, Thies J, Van Hove JLK, Hingorani SR, Lam C (2018) COQ2 nephropathy: a treatable cause of nephrotic syndrome in children. Pediat Nephrol (Berlin, Germany) 33(7):1257\u20131261. https:\/\/doi.org\/10.1007\/s00467-018-3937-z","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"key":"4519_CR104","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pediatrneurol.2018.07.008","volume":"88","author":"FK Eroglu","year":"2018","unstructured":"Eroglu FK, Ozaltin F, Gonc N, Nalcacioglu H, Ozcakar ZB, Yalnizoglu D, Gucer S, Orhan D, Eminoglu FT, Gocmen R, Alikasifoglu A, Topaloglu R, Duzova A (2018) Response to early coenzyme Q10 supplementation is not sustained in CoQ10 deficiency caused by CoQ2 mutation. Pediatr Neurol 88:71\u201374. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2018.07.008","journal-title":"Pediatr Neurol"},{"key":"4519_CR105","doi-asserted-by":"publisher","unstructured":"Atmaca M, Gulhan B, Korkmaz E, Inozu M, Soylemezoglu O, Candan C, Bayazit AK, Elmaci AM, Parmaksiz G, Duzova A, Besbas N, Topaloglu R, Ozaltin F (2017) Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment 32(8):1369\u20131375. doi:https:\/\/doi.org\/10.1007\/s00467-017-3634-3","DOI":"10.1007\/s00467-017-3634-3"},{"issue":"1","key":"4519_CR106","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40620-016-0308-3","volume":"30","author":"KV Lieberman","year":"2017","unstructured":"Lieberman KV, Pavlova-Wolf A (2017) Adrenocorticotropic hormone therapy for the treatment of idiopathic nephrotic syndrome in children and young adults: a systematic review of early clinical studies with contemporary relevance. J Nephrol 30(1):35\u201344. https:\/\/doi.org\/10.1007\/s40620-016-0308-3","journal-title":"J Nephrol"},{"issue":"1","key":"4519_CR107","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12882-017-0644-0","volume":"18","author":"Y Awanami","year":"2017","unstructured":"Awanami Y, Fukuda M, Nonaka Y, Takashima T, Matsumoto K, Yamasaki M, Miyazono M, Ikeda Y (2017) Successful treatment of a patient with refractory nephrotic syndrome with PCSK9 inhibitors: a case report. BMC Nephrol 18(1):221. https:\/\/doi.org\/10.1186\/s12882-017-0644-0","journal-title":"BMC Nephrol"},{"issue":"3","key":"4519_CR108","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/1744-9987.12561","volume":"21","author":"H Suzuki","year":"2017","unstructured":"Suzuki H, Tsukamoto T, Muso E (2017) Rituximab-resistant nephrotic syndrome with successful induction of remission by low-density lipoprotein apheresis. Ther Apher Dial 21(3):295\u2013296. https:\/\/doi.org\/10.1111\/1744-9987.12561","journal-title":"Ther Apher Dial"},{"issue":"8","key":"4519_CR109","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00467-013-2435-6","volume":"28","author":"D Bockenhauer","year":"2013","unstructured":"Bockenhauer D (2013) Over- or underfill: not all nephrotic states are created equal. Pediat Nephrol (Berlin, Germany) 28(8):1153\u20131156. https:\/\/doi.org\/10.1007\/s00467-013-2435-6","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"7","key":"4519_CR110","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00467-013-2567-8","volume":"29","author":"MA Cadnapaphornchai","year":"2014","unstructured":"Cadnapaphornchai MA, Tkachenko O, Shchekochikhin D, Schrier RW (2014) The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications. Pediat Nephrol (Berlin, Germany) 29(7):1159\u20131167. https:\/\/doi.org\/10.1007\/s00467-013-2567-8","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"5","key":"4519_CR111","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1046\/j.1523-1755.1998.00864.x","volume":"53","author":"RW Schrier","year":"1998","unstructured":"Schrier RW, Fassett RG (1998) A critique of the overfill hypothesis of sodium and water retention in the nephrotic syndrome. Kidney Int 53(5):1111\u20131117. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00864.x","journal-title":"Kidney Int"},{"issue":"2","key":"4519_CR112","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1681\/ASN.V102323","volume":"10","author":"JG Vande Walle","year":"1999","unstructured":"Vande Walle JG, Donckerwolcke RA, Koomans HA (1999) Pathophysiology of edema formation in children with nephrotic syndrome not due to minimal change disease. J Am Soc Nephrol 10(2):323\u2013331","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4519_CR113","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2215\/cjn.04390808","volume":"4","author":"G Kapur","year":"2009","unstructured":"Kapur G, Valentini RP, Imam AA, Mattoo TK (2009) Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study. Clin J Am Soc Nephrol 4(5):907\u2013913. https:\/\/doi.org\/10.2215\/cjn.04390808","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"4519_CR114","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00467-015-3241-0","volume":"31","author":"J McCaffrey","year":"2016","unstructured":"McCaffrey J, Lennon R, Webb NJ (2016) The non-immunosuppressive management of childhood nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 31(9):1383\u20131402. https:\/\/doi.org\/10.1007\/s00467-015-3241-0","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"12","key":"4519_CR115","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.2215\/cjn.06620615","volume":"10","author":"MN Rheault","year":"2015","unstructured":"Rheault MN, Zhang L, Selewski DT, Kallash M, Tran CL, Seamon M, Katsoufis C, Ashoor I, Hernandez J, Supe-Markovina K, D'Alessandri-Silva C, DeJesus-Gonzalez N, Vasylyeva TL, Formeck C, Woll C, Gbadegesin R, Geier P, Devarajan P, Carpenter SL, Kerlin BA, Smoyer WE (2015) AKI in children hospitalized with nephrotic syndrome. Clin J Am Soc Nephrol 10(12):2110\u20132118. https:\/\/doi.org\/10.2215\/cjn.06620615","journal-title":"Clin J Am Soc Nephrol"},{"key":"4519_CR116","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.3389\/fphys.2018.01868","volume":"9","author":"S Gupta","year":"2018","unstructured":"Gupta S, Pepper RJ, Ashman N, Walsh SB (2018) Nephrotic syndrome: oedema formation and its treatment with diuretics. Front Physiol 9:1868. https:\/\/doi.org\/10.3389\/fphys.2018.01868","journal-title":"Front Physiol"},{"issue":"3","key":"4519_CR117","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.ajkd.2016.10.022","volume":"69","author":"MA Fallahzadeh","year":"2017","unstructured":"Fallahzadeh MA, Dormanesh B, Fallahzadeh MK, Roozbeh J, Fallahzadeh MH, Sagheb MM (2017) Acetazolamide and hydrochlorothiazide followed by furosemide versus furosemide and hydrochlorothiazide followed by furosemide for the treatment of adults with nephrotic edema: a randomized trial. Am J Kidney Dis 69(3):420\u2013427. https:\/\/doi.org\/10.1053\/j.ajkd.2016.10.022","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"4519_CR118","first-page":"1111","volume":"125","author":"G Lemieux","year":"1981","unstructured":"Lemieux G, Beauchemin M, Gougoux A, Vinay P (1981) Treatment of nephrotic edema with bumetanide. Can Med Assoc J 125(10):1111\u20131112 1117","journal-title":"Can Med Assoc J"},{"issue":"7","key":"4519_CR119","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/archpedi.1987.04460070071028","volume":"141","author":"EH Garin","year":"1987","unstructured":"Garin EH (1987) A comparison of combinations of diuretics in nephrotic edema. Am J Dis Children (1960) 141(7):769\u2013771. https:\/\/doi.org\/10.1001\/archpedi.1987.04460070071028","journal-title":"Am J Dis Children (1960)"},{"issue":"3","key":"4519_CR120","first-page":"29","volume":"2","author":"SOH Mahdavinia","year":"2016","unstructured":"Mahdavinia SOH, Hoseini R, Shheikhvatan M (2016) Amiloride vs hydrochlorthiazide therapy in children with ne- phrotic syndrome: a clinical trial. Int J Children Adolesc 2(3):29\u201331","journal-title":"Int J Children Adolesc"},{"issue":"2","key":"4519_CR121","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1203\/00006450-198302000-00012","volume":"17","author":"J Prandota","year":"1983","unstructured":"Prandota J (1983) Pharmacokinetics of furosemide urinary elimination by nephrotic children. Pediatr Res 17(2):141\u2013147. https:\/\/doi.org\/10.1203\/00006450-198302000-00012","journal-title":"Pediatr Res"},{"issue":"5","key":"4519_CR122","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1542\/peds.62.5.811","volume":"62","author":"MA Engle","year":"1978","unstructured":"Engle MA, Lewy JE, Lewy PR, Metcoff J (1978) The use of furosemide in the treatment of edema in infants and children. Pediatrics 62(5):811\u2013818","journal-title":"Pediatrics"},{"issue":"2","key":"4519_CR123","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1046\/j.1523-1755.1999.00298.x","volume":"55","author":"D Fliser","year":"1999","unstructured":"Fliser D, Zurbruggen I, Mutschler E, Bischoff I, Nussberger J, Franek E, Ritz E (1999) Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int 55(2):629\u2013634. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00298.x","journal-title":"Kidney Int"},{"issue":"4","key":"4519_CR124","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00467-008-1062-0","volume":"24","author":"R Dharmaraj","year":"2009","unstructured":"Dharmaraj R, Hari P, Bagga A (2009) Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 24(4):775\u2013782. https:\/\/doi.org\/10.1007\/s00467-008-1062-0","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"2","key":"4519_CR125","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jcrc.2013.10.004","volume":"29","author":"GD Kitsios","year":"2014","unstructured":"Kitsios GD, Mascari P, Ettunsi R, Gray AW (2014) Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis. J Crit Care 29(2):253\u2013259. https:\/\/doi.org\/10.1016\/j.jcrc.2013.10.004","journal-title":"J Crit Care"},{"issue":"6","key":"4519_CR126","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1542\/peds.91.6.1142","volume":"91","author":"RM Haws","year":"1993","unstructured":"Haws RM, Baum M (1993) Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics 91(6):1142\u20131146","journal-title":"Pediatrics"},{"issue":"3","key":"4519_CR127","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2450\/2009.0094-09","volume":"7","author":"GM Liumbruno","year":"2009","unstructured":"Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossettias G (2009) Recommendations for the use of albumin and immunoglobulins. Blood Transfus 7(3):216\u2013234. https:\/\/doi.org\/10.2450\/2009.0094-09","journal-title":"Blood Transfus"},{"issue":"7022","key":"4519_CR128","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/bmj.312.7022.36","volume":"312","author":"CJ Reid","year":"1996","unstructured":"Reid CJ, Marsh MJ, Murdoch IM, Clark G (1996) Nephrotic syndrome in childhood complicated by life threatening pulmonary oedema. BMJ (Clin Res ed) 312(7022):36\u201338. https:\/\/doi.org\/10.1136\/bmj.312.7022.36","journal-title":"BMJ (Clin Res ed)"},{"issue":"11 Pt 1","key":"4519_CR129","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1753-4887.1996.tb03800.x","volume":"54","author":"R Rodrigo","year":"1996","unstructured":"Rodrigo R, Bravo I, Pino M (1996) Proteinuria and albumin homeostasis in the nephrotic syndrome: effect of dietary protein intake. Nutr Rev 54(11 Pt 1):337\u2013347. https:\/\/doi.org\/10.1111\/j.1753-4887.1996.tb03800.x","journal-title":"Nutr Rev"},{"issue":"8","key":"4519_CR130","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00467-019-04229-3","volume":"34","author":"CB Sethna","year":"2019","unstructured":"Sethna CB, Ng DK, Jiang S, Saland J, Warady BA, Furth S, Meyers KE (2019) Cardiovascular disease risk among children with focal segmental glomerulosclerosis: a report from the chronic kidney disease in children study. Pediat Nephrol (Berlin, Germany) 34(8):1403\u20131412. https:\/\/doi.org\/10.1007\/s00467-019-04229-3","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"7","key":"4519_CR131","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00431-014-2479-z","volume":"174","author":"D Ribeiro","year":"2015","unstructured":"Ribeiro D, Zawadynski S, Pittet LF, Chevalley T, Girardin E, Parvex P (2015) Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome. Eur J Pediatr 174(7):911\u2013917. https:\/\/doi.org\/10.1007\/s00431-014-2479-z","journal-title":"Eur J Pediatr"},{"key":"4519_CR132","doi-asserted-by":"publisher","unstructured":"Lee JM, Kronbichler A (2019) Review on long-term non-renal complications of childhood nephrotic syndrome. https:\/\/doi.org\/10.1111\/apa.15035","DOI":"10.1111\/apa.15035"},{"key":"4519_CR133","doi-asserted-by":"publisher","unstructured":"KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary (2009). American Journal of Kidney Diseases 53 (3 Suppl 2):S11\u2013104. doi:https:\/\/doi.org\/10.1053\/j.ajkd.2008.11.017","DOI":"10.1053\/j.ajkd.2008.11.017"},{"key":"4519_CR134","doi-asserted-by":"publisher","unstructured":"McAlister L, Pugh P, Greenbaum L, Haffner D, Rees L, Anderson C, Desloovere A, Nelms C, Oosterveld M, Paglialonga F, Polderman N, Qizalbash L, Renken-Terhaerdt J, Tuokkola J, Warady B, Walle JV, Shaw V, Shroff R (2019) The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce. doi:https:\/\/doi.org\/10.1007\/s00467-019-04370-z","DOI":"10.1007\/s00467-019-04370-z"},{"issue":"2","key":"4519_CR135","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s004670050246","volume":"11","author":"P Ljungberg","year":"1997","unstructured":"Ljungberg P, Holmberg C, Jalanko H (1997) Infections in infants with congenital nephrosis of the Finnish type. Pediat Nephrol (Berlin, Germany) 11(2):148\u2013152. https:\/\/doi.org\/10.1007\/s004670050246","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"key":"4519_CR136","unstructured":"Karim MYBBP (2018) Hypogammglobulinemia. BMJ Best Practices (bestpracticesbmjcom) Mar 21, 2018"},{"key":"4519_CR137","doi-asserted-by":"crossref","unstructured":"Minimal change nephrotic syndrome in children: Deaths during the first 5 to 15 years\u2019 observation. Report of the International Study of Kidney Disease in Children (1984). Pediatrics 73(4):497\u2013501","DOI":"10.1542\/peds.73.4.497"},{"issue":"1","key":"4519_CR138","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13052-017-0356-x","volume":"43","author":"A Pasini","year":"2017","unstructured":"Pasini A, Benetti E, Conti G, Ghio L, Lepore M, Massella L, Molino D, Peruzzi L, Emma F, Fede C, Trivelli A, Maringhini S, Materassi M, Messina G, Montini G, Murer L, Pecoraro C, Pennesi M (2017) The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: part I - diagnosis and treatment of the first episode and the first relapse. Ital J Pediatr 43(1):41. https:\/\/doi.org\/10.1186\/s13052-017-0356-x","journal-title":"Ital J Pediatr"},{"key":"4519_CR139","unstructured":"Nuorti JP, Whitney CG (2010) Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports 59 (Rr-11):1-18"},{"issue":"2","key":"4519_CR140","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1542\/peds.2008-1559","volume":"124","author":"DS Gipson","year":"2009","unstructured":"Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA (2009) Management of childhood onset nephrotic syndrome. Pediatrics 124(2):747\u2013757. https:\/\/doi.org\/10.1542\/peds.2008-1559","journal-title":"Pediatrics"},{"key":"4519_CR141","doi-asserted-by":"publisher","unstructured":"Wu HM, Tang JL, Cao L, Sha ZH, Li Y (2012) Interventions for preventing infection in nephrotic syndrome. The Cochrane Database of Systematic Reviews (4):Cd003964. doi:https:\/\/doi.org\/10.1002\/14651858.CD003964.pub3","DOI":"10.1002\/14651858.CD003964.pub3"},{"issue":"1","key":"4519_CR142","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/0971-4065.41289","volume":"18","author":"A Bagga","year":"2008","unstructured":"Bagga A (2008) Revised guidelines for management of steroid-sensitive nephrotic syndrome. Indian J Nephrol 18(1):31\u201339. https:\/\/doi.org\/10.4103\/0971-4065.41289","journal-title":"Indian J Nephrol"},{"issue":"1","key":"4519_CR143","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00431-009-0989-x","volume":"169","author":"N Uncu","year":"2010","unstructured":"Uncu N, Bulbul M, Yildiz N, Noyan A, Kosan C, Kavukcu S, Caliskan S, Gunduz Z, Besbas N, Gur Guven A (2010) Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study. Eur J Pediatr 169(1):73\u201376. https:\/\/doi.org\/10.1007\/s00431-009-0989-x","journal-title":"Eur J Pediatr"},{"issue":"6","key":"4519_CR144","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1542\/peds.81.6.849","volume":"81","author":"MJ Gorensek","year":"1988","unstructured":"Gorensek MJ, Lebel MH, Nelson JD (1988) Peritonitis in children with nephrotic syndrome. Pediatrics 81(6):849\u2013856","journal-title":"Pediatrics"},{"issue":"8","key":"4519_CR145","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/archpedi.1982.03970440076023","volume":"136","author":"AM Krensky","year":"1982","unstructured":"Krensky AM, Ingelfinger JR, Grupe WE (1982) Peritonitis in childhood nephrotic syndrome: 1970-1980. Am J Dis Children (1960) 136(8):732\u2013736. https:\/\/doi.org\/10.1001\/archpedi.1982.03970440076023","journal-title":"Am J Dis Children (1960)"},{"issue":"3","key":"4519_CR146","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00006454-199603000-00012","volume":"15","author":"S Gulati","year":"1996","unstructured":"Gulati S, Kher V, Arora P, Gupta S, Kale S (1996) Urinary tract infection in nephrotic syndrome. Pediatr Infect Dis J 15(3):237\u2013240. https:\/\/doi.org\/10.1097\/00006454-199603000-00012","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"4519_CR147","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1440-1754.1998.00232.x","volume":"34","author":"P McIntyre","year":"1998","unstructured":"McIntyre P, Craig JC (1998) Prevention of serious bacterial infection in children with nephrotic syndrome. J Paediatr Child Health 34(4):314\u2013317. https:\/\/doi.org\/10.1046\/j.1440-1754.1998.00232.x","journal-title":"J Paediatr Child Health"},{"key":"4519_CR148","unstructured":"HHS (2016) HHS Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Department of Health and Human Services Available at http:\/\/aidsinfonih.gov\/contentfiles\/lvguidelines\/oi_guidelines_pediatrics.pdf Accessed 2016"},{"key":"4519_CR149","unstructured":"HHS (2017) HHS Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at http:\/\/aidsinfonih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf. Accessed 2017"},{"key":"4519_CR150","doi-asserted-by":"crossref","unstructured":"FDA approval of an extended period for administering VariZIG for postexposure prophylaxis of varicella (2012). MMWR Morbidity and mortality weekly report 61(12):212","DOI":"10.1111\/j.1600-6143.2012.04257.x"},{"key":"4519_CR151","unstructured":"Updated recommendations for use of VariZIG--United States, 2013 (2013). MMWR Morb Mortal Wkly Rep 62 (28):574\u2013576"},{"key":"4519_CR152","first-page":"2012","volume-title":"FDA approves VariZIG for reducing chickenpox symptoms","author":"Administration FaD","year":"2012","unstructured":"Administration FaD (2012) FDA approves VariZIG for reducing chickenpox symptoms. Food and Drug Administration, Silver Spring, p 2012"},{"issue":"Rr-4","key":"4519_CR153","first-page":"1","volume":"56","author":"M Marin","year":"2007","unstructured":"Marin M, Guris D, Chaves SS, Schmid S, Seward JF (2007) Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports : morbidity and mortality weekly report. Recommen Reports 56(Rr-4):1\u201340","journal-title":"Recommen Reports"},{"issue":"7","key":"4519_CR154","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217749","volume":"14","author":"MJ Levin","year":"2019","unstructured":"Levin MJ, Duchon JM, Swamy GK, Gershon AA (2019) Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: varicella outcomes and safety results from a large, open-label, expanded-access program. PLoS One 14(7):e0217749. https:\/\/doi.org\/10.1371\/journal.pone.0217749","journal-title":"PLoS One"},{"issue":"12","key":"4519_CR155","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1097\/00006454-199712000-00012","volume":"16","author":"TY Lin","year":"1997","unstructured":"Lin TY, Huang YC, Ning HC, Hsueh C (1997) Oral acyclovir prophylaxis of varicella after intimate contact. Pediatr Infect Dis J 16(12):1162\u20131165. https:\/\/doi.org\/10.1097\/00006454-199712000-00012","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"4519_CR156","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1542\/peds.92.2.219","volume":"92","author":"Y Asano","year":"1993","unstructured":"Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T, Ozaki T, Yamada A, Imanishi J (1993) Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 92(2):219\u2013222","journal-title":"Pediatrics"},{"issue":"4","key":"4519_CR157","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s004670050764","volume":"14","author":"SL Goldstein","year":"2000","unstructured":"Goldstein SL, Somers MJ, Lande MB, Brewer ED, Jabs KL (2000) Acyclovir prophylaxis of varicella in children with renal disease receiving steroids. Pediat Nephrol (Berlin, Germany) 14(4):305\u2013308. https:\/\/doi.org\/10.1007\/s004670050764","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"6","key":"4519_CR158","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00467-013-2525-5","volume":"29","author":"BA Kerlin","year":"2014","unstructured":"Kerlin BA, Haworth K, Smoyer WE (2014) Venous thromboembolism in pediatric nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 29(6):989\u2013997. https:\/\/doi.org\/10.1007\/s00467-013-2525-5","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"1","key":"4519_CR159","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/bf00863459","volume":"10","author":"M Andrew","year":"1996","unstructured":"Andrew M, Brooker LA (1996) Hemostatic complications in renal disorders of the young. Pediat Nephrol (Berlin, Germany) 10(1):88\u201399. https:\/\/doi.org\/10.1007\/bf00863459","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"1\u20132","key":"4519_CR160","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s004679900253","volume":"15","author":"MI Lilova","year":"2000","unstructured":"Lilova MI, Velkovski IG, Topalov IB (2000) Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974-1996). Pediat Nephrol (Berlin, Germany) 15(1\u20132):74\u201378. https:\/\/doi.org\/10.1007\/s004679900253","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"key":"4519_CR161","doi-asserted-by":"publisher","unstructured":"Carpenter SL, Goldman J, Sherman AK, Selewski DT, Kallash M, Tran CL, Seamon M, Katsoufis C, Ashoor I, Hernandez J, Supe-Markovina K, D'Alessandri-Silva C, DeJesus-Gonzalez N, Vasylyeva TL, Formeck C, Woll C, Gbadegesin R, Geier P, Devarajan P, Smoyer WE, Kerlin BA, Rheault MN (2019) Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome. 34(2):261-267. doi:https:\/\/doi.org\/10.1007\/s00467-018-4072-6","DOI":"10.1007\/s00467-018-4072-6"},{"issue":"1","key":"4519_CR162","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrneph.2017.155","volume":"14","author":"S Agrawal","year":"2018","unstructured":"Agrawal S, Zaritsky JJ, Fornoni A, Smoyer WE (2018) Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol 14(1):57\u201370. https:\/\/doi.org\/10.1038\/nrneph.2017.155","journal-title":"Nat Rev Nephrol"},{"key":"4519_CR163","doi-asserted-by":"publisher","unstructured":"Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L (2013) Lipid-lowering agents for nephrotic syndrome. The Cochrane database of systematic reviews (12):Cd005425. doi:https:\/\/doi.org\/10.1002\/14651858.CD005425.pub2","DOI":"10.1002\/14651858.CD005425.pub2"},{"issue":"1","key":"4519_CR164","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/0974-2069.79633","volume":"4","author":"SP Suryawanshi","year":"2011","unstructured":"Suryawanshi SP, Das B, Patnaik AN (2011) Myocardial infarction in children: two interesting cases. Ann Pediatr Cardiol 4(1):81\u201383. https:\/\/doi.org\/10.4103\/0974-2069.79633","journal-title":"Ann Pediatr Cardiol"},{"issue":"3","key":"4519_CR165","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00467-001-0793-y","volume":"17","author":"JM Silva","year":"2002","unstructured":"Silva JM, Oliveira EA, Marino VS, Oliveira JS, Torres RM, Ribeiro AL, Simal CJ, Ribeiro MC (2002) Premature acute myocardial infarction in a child with nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 17(3):169\u2013172. https:\/\/doi.org\/10.1007\/s00467-001-0793-y","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"key":"4519_CR166","doi-asserted-by":"publisher","unstructured":"Hari P, Khandelwal P, Smoyer WE (2019) Dyslipidemia and cardiovascular health in childhood nephrotic syndrome. Pediatr Nephrol (Berlin). https:\/\/doi.org\/10.1007\/s00467-019-04301-y","DOI":"10.1007\/s00467-019-04301-y"},{"issue":"2","key":"4519_CR167","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/bf00862065","volume":"10","author":"JE Coleman","year":"1996","unstructured":"Coleman JE, Watson AR (1996) Hyperlipidaemia, diet and simvastatin therapy in steroid-resistant nephrotic syndrome of childhood. Pediat Nephrol (Berlin, Germany) 10(2):171\u2013174. https:\/\/doi.org\/10.1007\/bf00862065","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"3","key":"4519_CR168","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/s0022-3476(97)70213-0","volume":"130","author":"SA Sanjad","year":"1997","unstructured":"Sanjad SA, al-Abbad A, al-Shorafa S (1997) Management of hyperlipidemia in children with refractory nephrotic syndrome: the effect of statin therapy. J Pediatr 130(3):470\u2013474. https:\/\/doi.org\/10.1016\/s0022-3476(97)70213-0","journal-title":"J Pediatr"},{"issue":"12","key":"4519_CR169","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s00467-018-4036-x","volume":"33","author":"P Hari","year":"2018","unstructured":"Hari P, Khandelwal P, Satpathy A, Hari S, Thergaonkar R, Lakshmy R, Sinha A, Bagga A (2018) Effect of atorvastatin on dyslipidemia and carotid intima-media thickness in children with refractory nephrotic syndrome: a randomized controlled trial. Pediat Nephrol (Berlin, Germany) 33(12):2299\u20132309. https:\/\/doi.org\/10.1007\/s00467-018-4036-x","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"3","key":"4519_CR170","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s10157-015-1216-x","volume":"20","author":"S Nishi","year":"2016","unstructured":"Nishi S, Ubara Y, Utsunomiya Y, Okada K, Obata Y, Kai H, Kiyomoto H, Goto S, Konta T, Sasatomi Y, Sato Y, Nishino T, Tsuruya K, Furuichi K, Hoshino J, Watanabe Y, Kimura K, Matsuo S (2016) Evidence-based clinical practice guidelines for nephrotic syndrome 2014. Clin Exp Nephrol 20(3):342\u2013370. https:\/\/doi.org\/10.1007\/s10157-015-1216-x","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"4519_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000183106","volume":"36","author":"U Alon","year":"1984","unstructured":"Alon U, Chan JC (1984) Calcium and vitamin D homeostasis in the nephrotic syndrome: current status. Nephron 36(1):1\u20134. https:\/\/doi.org\/10.1159\/000183106","journal-title":"Nephron"},{"issue":"3","key":"4519_CR172","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00467-015-3236-x","volume":"31","author":"DT Selewski","year":"2016","unstructured":"Selewski DT, Chen A, Shatat IF, Pais P, Greenbaum LA, Geier P, Nelson RD, Kiessling SG, Brophy PD, Quiroga A, Seifert ME, Straatmann CE, Mahan JD, Ferris ME, Troost JP, Gipson DS (2016) Vitamin D in incident nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study. Pediat Nephrol (Berlin, Germany) 31(3):465\u2013472. https:\/\/doi.org\/10.1007\/s00467-015-3236-x","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"4","key":"4519_CR173","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/mnh.0000000000000233","volume":"25","author":"MR Denburg","year":"2016","unstructured":"Denburg MR (2016) Skeletal manifestations of renal disease in childhood. Curr Opin Nephrol Hypertens 25(4):292\u2013300. https:\/\/doi.org\/10.1097\/mnh.0000000000000233","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"4519_CR174","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/20469047.2018.1505589","volume":"38","author":"DN Singh","year":"2018","unstructured":"Singh DN, Krishnamurthy S, Kamalanathan SK, Harichandrakumar KT, Sivamurukan P (2018) Three-monthly bolus vitamin D supplements (1000 vs 400 IU\/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial. Paediatr Int Child Health 38(4):251\u2013260. https:\/\/doi.org\/10.1080\/20469047.2018.1505589","journal-title":"Paediatr Int Child Health"},{"issue":"7","key":"4519_CR175","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/ndt\/gfx080","volume":"32","author":"R Shroff","year":"2017","unstructured":"Shroff R, Wan M, Nagler EV, Bakkaloglu S, Cozzolino M, Bacchetta J, Edefonti A, Stefanidis CJ, Vande Walle J, Ariceta G, Klaus G, Haffner D, Schmitt CP (2017) Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease stages 2-5 and on dialysis. Nephrol Dial Transplant 32(7):1114\u20131127. https:\/\/doi.org\/10.1093\/ndt\/gfx080","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"4519_CR176","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/bf00856516","volume":"8","author":"S Ito","year":"1994","unstructured":"Ito S, Kano K, Ando T, Ichimura T (1994) Thyroid function in children with nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 8(4):412\u2013415. https:\/\/doi.org\/10.1007\/bf00856516","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"6","key":"4519_CR177","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/ndt\/gfr665","volume":"27","author":"A Dagan","year":"2012","unstructured":"Dagan A, Cleper R, Krause I, Blumenthal D, Davidovits M (2012) Hypothyroidism in children with steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 27(6):2171\u20132175. https:\/\/doi.org\/10.1093\/ndt\/gfr665","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"4519_CR178","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10157-013-0800-1","volume":"18","author":"K Kapoor","year":"2014","unstructured":"Kapoor K, Saha A, Dubey NK, Goyal P, Suresh CP, Batra V, Upadhayay AD (2014) Subclinical non-autoimmune hypothyroidism in children with steroid resistant nephrotic syndrome. Clin Exp Nephrol 18(1):113\u2013117. https:\/\/doi.org\/10.1007\/s10157-013-0800-1","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"4519_CR179","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2174\/1871530315666150930121644","volume":"15","author":"S Sharma","year":"2015","unstructured":"Sharma S, Dabla PK, Kumar M (2015) Evaluation of thyroid hormone status in children with steroid resistant nephrotic syndrome: a North India study. Endocr Metab Immune Disord Drug Targets 15(4):321\u2013324","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"9","key":"4519_CR180","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1210\/js.2017-00471","volume":"2","author":"MC Vigone","year":"2018","unstructured":"Vigone MC, Capalbo D, Weber G, Salerno M (2018) Mild hypothyroidism in childhood: who, when, and how should be treated? J Endocrine Soc 2(9):1024\u20131039. https:\/\/doi.org\/10.1210\/js.2017-00471","journal-title":"J Endocrine Soc"},{"issue":"12","key":"4519_CR181","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/nrendo.2016.100","volume":"12","author":"M Salerno","year":"2016","unstructured":"Salerno M, Capalbo D, Cerbone M, De Luca F (2016) Subclinical hypothyroidism in childhood - current knowledge and open issues. Nat Rev Endocrinol 12(12):734\u2013746. https:\/\/doi.org\/10.1038\/nrendo.2016.100","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"4519_CR182","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1097\/HJH.0b013e32832f4f6b","volume":"27","author":"E Lurbe","year":"2009","unstructured":"Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, Kuznetsova T, Laurent S, Mancia G, Morales-Olivas F, Rascher W, Redon J, Schaefer F, Seeman T, Stergiou G, Wuhl E, Zanchetti A (2009) Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 27(9):1719\u20131742. https:\/\/doi.org\/10.1097\/HJH.0b013e32832f4f6b","journal-title":"J Hypertens"},{"issue":"10","key":"4519_CR183","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/hjh.0000000000001039","volume":"34","author":"E Lurbe","year":"2016","unstructured":"Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, Invitti C, Litwin M, Mancia G, Pall D, Rascher W, Redon J, Schaefer F, Seeman T, Sinha M, Stabouli S, Webb NJ, Wuhl E, Zanchetti A (2016) 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34(10):1887\u20131920. https:\/\/doi.org\/10.1097\/hjh.0000000000001039","journal-title":"J Hypertens"},{"issue":"1","key":"4519_CR184","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB (2017) Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what\u2019s changed and why it matters. Kidney Int 92(1):26\u201336. https:\/\/doi.org\/10.1016\/j.kint.2017.04.006","journal-title":"Kidney Int"},{"issue":"11","key":"4519_CR185","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s00467-009-1264-0","volume":"24","author":"Y Hamasaki","year":"2009","unstructured":"Hamasaki Y, Yoshikawa N, Hattori S, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ishikura K, Yata N, Kaneko T, Honda M (2009) Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome. Pediat Nephrol (Berlin, Germany) 24(11):2177\u20132185. https:\/\/doi.org\/10.1007\/s00467-009-1264-0","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"1","key":"4519_CR186","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4103\/ijn.IJN_240_16","volume":"28","author":"N Prasad","year":"2018","unstructured":"Prasad N, Manjunath R, Rangaswamy D, Jaiswal A, Agarwal V, Bhadauria D, Kaul A, Sharma R, Gupta A (2018) Efficacy and safety of cyclosporine versus tacrolimus in steroid and cyclophosphamide resistant nephrotic syndrome: a prospective study. Indian J Nephrol 28(1):46\u201352. https:\/\/doi.org\/10.4103\/ijn.IJN_240_16","journal-title":"Indian J Nephrol"},{"issue":"8","key":"4519_CR187","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s00467-003-1174-5","volume":"18","author":"B Montane","year":"2003","unstructured":"Montane B, Abitbol C, Chandar J, Strauss J, Zilleruelo G (2003) Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade. Pediat Nephrol (Berlin, Germany) 18(8):772\u2013777. https:\/\/doi.org\/10.1007\/s00467-003-1174-5","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"issue":"12","key":"4519_CR188","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1097\/tp.0000000000001846","volume":"101","author":"LS Feltran","year":"2017","unstructured":"Feltran LS, Varela P, Silva ED, Veronez CL, Franco MC, Filho AP, Camargo MF, Koch Nogueira PC, Pesquero JB (2017) Targeted next-generation sequencing in Brazilian children with nephrotic syndrome submitted to renal transplant. Transplantation 101(12):2905\u20132912. https:\/\/doi.org\/10.1097\/tp.0000000000001846","journal-title":"Transplantation"},{"issue":"6","key":"4519_CR189","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1681\/asn.2013080852","volume":"25","author":"WY Ding","year":"2014","unstructured":"Ding WY, Koziell A, McCarthy HJ, Bierzynska A, Bhagavatula MK, Dudley JA, Inward CD, Coward RJ, Tizard J, Reid C, Antignac C, Boyer O, Saleem MA (2014) Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence. J Am Soc Nephrol 25(6):1342\u20131348. https:\/\/doi.org\/10.1681\/asn.2013080852","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"4519_CR190","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1034\/j.1399-3046.2001.005002105.x","volume":"5","author":"SJ Kim","year":"2001","unstructured":"Kim SJ, Ha J, Jung IM, Ahn MS, Kim M, Lee HS, Cheong HI, Choi Y (2001) Recurrent focal segmental glomerulosclerosis following renal transplantation in Korean pediatric patients. Pediatr Transplant 5(2):105\u2013111","journal-title":"Pediatr Transplant"},{"issue":"5","key":"4519_CR191","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13185","volume":"22","author":"A Francis","year":"2018","unstructured":"Francis A, Didsbury M, McCarthy H, Kara T (2018) Treatment of recurrent focal segmental glomerulosclerosis post-kidney transplantation in Australian and New Zealand children: a retrospective cohort study. Pediatr Transplant 22(5):e13185. https:\/\/doi.org\/10.1111\/petr.13185","journal-title":"Pediatr Transplant"},{"issue":"2","key":"4519_CR192","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1056\/NEJMoa013036","volume":"347","author":"EM Briganti","year":"2002","unstructured":"Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ (2002) Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347(2):103\u2013109. https:\/\/doi.org\/10.1056\/NEJMoa013036","journal-title":"N Engl J Med"},{"issue":"8S Suppl 1","key":"4519_CR193","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/tp.0000000000001769","volume":"101","author":"KL Lentine","year":"2017","unstructured":"Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberu J, Bakr MA, Gallon L, Garvey CA, Guleria S, Li PK, Segev DL, Taler SJ, Tanabe K, Wright L, Zeier MG, Cheung M, Garg AX (2017) KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation 101(8S Suppl 1):S1\u2013s109. https:\/\/doi.org\/10.1097\/tp.0000000000001769","journal-title":"Transplantation"},{"issue":"7","key":"4519_CR194","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/TP.0b013e318247a7b7","volume":"93","author":"PA Andrews","year":"2012","unstructured":"Andrews PA, Burnapp L, Manas D, Bradley JA, Dudley C (2012) Summary of the British Transplantation Society\/Renal Association U.K. guidelines for living donor kidney transplantation. Transplantation 93(7):666\u2013673. https:\/\/doi.org\/10.1097\/TP.0b013e318247a7b7","journal-title":"Transplantation"},{"issue":"5","key":"4519_CR195","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1093\/ndt\/gfn635","volume":"24","author":"O Gross","year":"2009","unstructured":"Gross O, Weber M, Fries JW, Muller GA (2009) Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome. Nephrol Dial Transplant 24(5):1626\u20131630. https:\/\/doi.org\/10.1093\/ndt\/gfn635","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"4519_CR196","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/ki.2008.693","volume":"75","author":"F Hildebrandt","year":"2009","unstructured":"Hildebrandt F, Heeringa SF (2009) Specific podocin mutations determine age of onset of nephrotic syndrome all the way into adult life. Kidney Int 75(7):669\u2013671. https:\/\/doi.org\/10.1038\/ki.2008.693","journal-title":"Kidney Int"},{"issue":"7","key":"4519_CR197","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1016\/j.bbadis.2018.04.008","volume":"1864","author":"P Straner","year":"2018","unstructured":"Straner P, Balogh E, Schay G, Arrondel C, Miko A, L'Aune G, Benmerah A, Perczel A, D KM, Antignac C, Mollet G, Tory K (2018) C-terminal oligomerization of podocin mediates interallelic interactions. Biochim Biophys Acta Mol basis Dis 1864(7):2448\u20132457. https:\/\/doi.org\/10.1016\/j.bbadis.2018.04.008","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"10","key":"4519_CR198","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s00467-015-3062-1","volume":"30","author":"R Trachtman","year":"2015","unstructured":"Trachtman R, Sran SS, Trachtman H (2015) Recurrent focal segmental glomerulosclerosis after kidney transplantation. Pediat Nephrol (Berlin, Germany) 30(10):1793\u20131802. https:\/\/doi.org\/10.1007\/s00467-015-3062-1","journal-title":"Pediat Nephrol (Berlin, Germany)"},{"key":"4519_CR199","first-page":"S44","volume":"19","author":"JE Striegel","year":"1986","unstructured":"Striegel JE, Sibley RK, Fryd DS, Mauer SM (1986) Recurrence of focal segmental sclerosis in children following renal transplantation. Kidney Int Suppl 19:S44\u2013S50","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"4519_CR200","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/petr.12257","volume":"18","author":"SE Lee","year":"2014","unstructured":"Lee SE, Min SI, Kim YS, Ha J, Ha IS, Cheong HI, Kim SJ, Choi Y, Kang HG (2014) Recurrence of idiopathic focal segmental glomerulosclerosis after kidney transplantation: experience of a Korean tertiary center. Pediatr Transplant 18(4):369\u2013376. https:\/\/doi.org\/10.1111\/petr.12257","journal-title":"Pediatr Transplant"},{"key":"4519_CR201","first-page":"61","volume":"19","author":"RA Donckerwolcke","year":"1983","unstructured":"Donckerwolcke RA, Broyer M, Brunner FP, Brynger H, Jacobs C, Kramer P, Selwood NH, Wing AJ (1983) Combined report on regular dialysis and transplantation of children in Europe, XI, 1981. Proc Eur Dial Transpl Assoc Eur Dial Transpl Assoc 19:61\u201391","journal-title":"Proc Eur Dial Transpl Assoc Eur Dial Transpl Assoc"},{"issue":"1 Pt 2","key":"4519_CR202","first-page":"2117","volume":"21","author":"JS Cameron","year":"1989","unstructured":"Cameron JS, Senguttuvan P, Hartley B, Rigden SP, Chantler C, Koffman G, Williams DG, Ogg CS (1989) Focal segmental glomerulosclerosis in fifty-nine renal allografts from a single centre; analysis of risk factors for recurrence. Transplant Proc 21(1 Pt 2):2117\u20132118","journal-title":"Transplant Proc"},{"issue":"2","key":"4519_CR203","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1432-2277.2009.00977.x","volume":"23","author":"G Moroni","year":"2010","unstructured":"Moroni G, Gallelli B, Quaglini S, Banfi G, Montagnino G, Messa P (2010) Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis. Transpl Int 23(2):208\u2013216. https:\/\/doi.org\/10.1111\/j.1432-2277.2009.00977.x","journal-title":"Transpl Int"},{"key":"4519_CR204","doi-asserted-by":"publisher","first-page":"vi68","DOI":"10.1093\/ndt\/gfg1068","volume":"18 Suppl 6","author":"CG Newstead","year":"2003","unstructured":"Newstead CG (2003) Recurrent disease in renal transplants. Nephrol Dial Transplant 18 Suppl 6:vi68\u2013vi74. https:\/\/doi.org\/10.1093\/ndt\/gfg1068","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"4519_CR205","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/tp.0000000000001160","volume":"101","author":"C Garrouste","year":"2017","unstructured":"Garrouste C, Canaud G, Buchler M, Rivalan J, Colosio C, Martinez F, Aniort J, Dudreuilh C, Pereira B, Caillard S, Philipponnet C, Anglicheau D, Heng AE (2017) Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: clinical outcomes. Transplantation 101(3):649\u2013656. https:\/\/doi.org\/10.1097\/tp.0000000000001160","journal-title":"Transplantation"},{"issue":"1","key":"4519_CR206","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12882-016-0322-7","volume":"17","author":"A Kashgary","year":"2016","unstructured":"Kashgary A, Sontrop JM, Li L, Al-Jaishi AA, Habibullah ZN, Alsolaimani R, Clark WF (2016) The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: a systematic review and meta-analysis of 77 case-reports and case-series. BMC Nephrol 17(1):104. https:\/\/doi.org\/10.1186\/s12882-016-0322-7","journal-title":"BMC Nephrol"},{"issue":"1","key":"4519_CR207","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1399-0012.2008.00908.x","volume":"23","author":"A Sener","year":"2009","unstructured":"Sener A, Bella AJ, Nguan C, Luke PP, House AA (2009) Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function. Clin Transpl 23(1):96\u2013100. https:\/\/doi.org\/10.1111\/j.1399-0012.2008.00908.x","journal-title":"Clin Transpl"},{"issue":"5","key":"4519_CR208","first-page":"348","volume":"68","author":"F Fencl","year":"2016","unstructured":"Fencl F, Vondrak K, Rosik T, Zieg J, Chadimova M, Hacek J, Dusek J, Seeman T (2016) Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis: early treatment with plasmapheresis and immunoadsorption should be associated with better prognosis. Minerva Pediatr 68(5):348\u2013354","journal-title":"Minerva Pediatr"},{"issue":"2","key":"4519_CR209","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00007890-199102000-00025","volume":"51","author":"E Ingulli","year":"1991","unstructured":"Ingulli E, Tejani A (1991) Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience. Transplantation 51(2):401\u2013405. https:\/\/doi.org\/10.1097\/00007890-199102000-00025","journal-title":"Transplantation"},{"issue":"10","key":"4519_CR210","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.transproceed.2017.10.001","volume":"49","author":"O Staeck","year":"2017","unstructured":"Staeck O, Halleck F, Budde K, Khadzhynov D (2017) Long-term outcomes of kidney transplant recipients with primary idiopathic focal segmental glomerulosclerosis. Transplant Proc 49(10):2256\u20132259. https:\/\/doi.org\/10.1016\/j.transproceed.2017.10.001","journal-title":"Transplant Proc"},{"issue":"11","key":"4519_CR211","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.2215\/cjn.03060316","volume":"11","author":"A Francis","year":"2016","unstructured":"Francis A, Trnka P, McTaggart SJ (2016) Long-term outcome of kidney transplantation in recipients with focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 11(11):2041\u20132046. https:\/\/doi.org\/10.2215\/cjn.03060316","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12 Suppl","key":"4519_CR212","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1681\/ASN.V212s258","volume":"2","author":"A Tejani","year":"1992","unstructured":"Tejani A, Stablein DH (1992) Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 2(12 Suppl):S258\u2013S263","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"4519_CR213","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.kint.2017.03.015","volume":"92","author":"PJ Allen","year":"2017","unstructured":"Allen PJ, Chadban SJ, Craig JC, Lim WH, Allen RDM, Clayton PA, Teixeira-Pinto A, Wong G (2017) Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes. Kidney Int 92(2):461\u2013469. https:\/\/doi.org\/10.1016\/j.kint.2017.03.015","journal-title":"Kidney Int"},{"issue":"2","key":"4519_CR214","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1053\/ajkd.2001.21311","volume":"37","author":"KC Abbott","year":"2001","unstructured":"Abbott KC, Sawyers ES, Oliver JD 3rd, Ko CW, Kirk AD, Welch PG, Peters TG, Agodoa LY (2001) Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 37(2):366\u2013373. https:\/\/doi.org\/10.1053\/ajkd.2001.21311","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"4519_CR215","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/j.1432-2277.2007.00562.x","volume":"20","author":"TN Meyer","year":"2007","unstructured":"Meyer TN, Thaiss F, Stahl RA (2007) Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transpl Int 20(12):1066\u20131071. https:\/\/doi.org\/10.1111\/j.1432-2277.2007.00562.x","journal-title":"Transpl Int"},{"issue":"12","key":"4519_CR216","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1111\/j.1600-6143.2005.01112.x","volume":"5","author":"RY Gohh","year":"2005","unstructured":"Gohh RY, Yango AF, Morrissey PE, Monaco AP, Gautam A, Sharma M, McCarthy ET, Savin VJ (2005) Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 5(12):2907\u20132912. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01112.x","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"5","key":"4519_CR217","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1111\/j.1432-2277.2012.01462.x","volume":"25","author":"V Audard","year":"2012","unstructured":"Audard V, Kamar N, Sahali D, Cardeau-Desangles I, Homs S, Remy P, Aouizerate J, Matignon M, Rostaing L, Lang P, Grimbert P (2012) Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation. Transpl Int 25(5):e62\u2013e66. https:\/\/doi.org\/10.1111\/j.1432-2277.2012.01462.x","journal-title":"Transpl Int"},{"issue":"10","key":"4519_CR218","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/ctr.12825","volume":"30","author":"R Cleper","year":"2016","unstructured":"Cleper R, Krause I, Bar Nathan N, Mor M, Dagan A, Weissman I, Frishberg Y, Rachamimov R, Mor E, Davidovits M (2016) Focal segmental glomerulosclerosis in pediatric kidney transplantation: 30 years' experience. Clin Transpl 30(10):1324\u20131331. https:\/\/doi.org\/10.1111\/ctr.12825","journal-title":"Clin Transpl"},{"issue":"5","key":"4519_CR219","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/ki.1994.188","volume":"45","author":"EM Kim","year":"1994","unstructured":"Kim EM, Striegel J, Kim Y, Matas AJ, Najarian JS, Mauer SM (1994) Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejection. Kidney Int 45(5):1440\u20131445. https:\/\/doi.org\/10.1038\/ki.1994.188","journal-title":"Kidney Int"},{"key":"4519_CR220","doi-asserted-by":"publisher","unstructured":"Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA (2018) Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings. 33(10):1773-1780. doi:https:\/\/doi.org\/10.1007\/s00467-018-3994-3","DOI":"10.1007\/s00467-018-3994-3"},{"issue":"4","key":"4519_CR221","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/ndt\/gfk005","volume":"21","author":"A Pardon","year":"2006","unstructured":"Pardon A, Audard V, Caillard S, Moulin B, Desvaux D, Bentaarit B, Remy P, Sahali D, Roudot-Thoraval F, Lang P, Grimbert P (2006) Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 21(4):1053\u20131059. https:\/\/doi.org\/10.1093\/ndt\/gfk005","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"4519_CR222","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1111\/j.1600-6143.2006.01361.x","volume":"6","author":"M Myslak","year":"2006","unstructured":"Myslak M, Amer H, Morales P, Fidler ME, Gloor JM, Larson TS, Stegall MD, Cosio FG (2006) Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 6(7):1660\u20131665. https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01361.x","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"key":"4519_CR223","doi-asserted-by":"publisher","first-page":"374213","DOI":"10.1155\/2011\/374213","volume":"2011","author":"CE Araya","year":"2011","unstructured":"Araya CE, Dharnidharka VR (2011) The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review. J Transplant 2011:374213. https:\/\/doi.org\/10.1155\/2011\/374213","journal-title":"J Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04519-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04519-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04519-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T03:15:29Z","timestamp":1666494929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04519-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":223,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4519"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04519-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,7]]},"assertion":[{"value":"21 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"D.H. has received research grants from Kyowa Kirin and Amgen, and has received speaker and\/or consultant fees from Amgen, Sandoz, Kyowa Kirin, Pfizer, Merck Serono, Horizon, and Chiesi. O.B. has received speaker and\/or consultant fees from Amgen, Chiesi, Novartis, and Octapharma. These were all unrelated to the topic of this guideline. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}